Sevelamer reduces endothelial inflammatory response to advanced glycation end products

BACKGROUND: Advanced glycation end products (AGEs) have been related to the pathogenesis of cardiovascular diseases (CVD), chronic kidney disease (CKD) and diabetes mellitus. We sought to investigate the binding capacity of sevelamer to both AGEs and uremic serum in vitro and then test this pharmace...

Full description

Saved in:
Bibliographic Details
Published in:Clin Kidney J
Main Authors: Gregório, Paulo C, Favretto, Giane, Sassaki, Guilherme L, Cunha, Regiane S, Becker-Finco, Alessandra, Pecoits-Filho, Roberto, Souza, Wesley M, Barreto, Fellype C, Stinghen, Andréa E M
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
CKD Complications
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798142/
https://ncbi.nlm.nih.gov/pubmed/29423208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx074
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items